Ambeed.cn

首页 / / / / Lificiguat

利非西呱 /Lificiguat {[allProObj[0].p_purity_real_show]}

货号:A174113 同义名: YC-1

Lificiguat结合可溶性鸟苷酸环化酶(sGC)的β亚基,在CO存在下Kd为0.6-1.1 μM。

Lificiguat 化学结构 CAS号:170632-47-0
Lificiguat 化学结构
CAS号:170632-47-0
Lificiguat 3D分子结构
CAS号:170632-47-0
Lificiguat 化学结构 CAS号:170632-47-0
Lificiguat 3D分子结构 CAS号:170632-47-0
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Lificiguat 纯度/质量文件 产品仅供科研

货号:A174113 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Cell, 2024, 101755. Ambeed. [ A399663 ]
EMBO J., 2024. Ambeed. [ A295334 ]
JMC, 2024, 67(20): 18265-18289. Ambeed. [ A538667 , A341145 , A117430 , A172297 ]
JMC, 2024. Ambeed. [ A210558 , A1518164 ]
Cell Death Discov., 2024, 10, 436. Ambeed. [ A384235 ]
更多 >
产品名称 HIF HIF1 PHD1 PHD2 PHD3 其他靶点 纯度
KC7F2 +

HIF-1α, IC50: 20 μM

+

HIF-1α, IC50: 20 μM

98%
Lificiguat 99%+
BAY 87-2243 99%+
PX-478·2HCl 98%+
2-Methoxyestradiol 98%
CAY10585 ++

HIF, IC50: 4.4 μM

BCRP 97%
DMOG 98%
FG 2216 ++

PHD2, IC50: 3.9 μM

99%+
MK-8617 ++++

PHD1, IC50: 1 nM

++++

PHD2, IC50: 1 nM

++++

PHD3, IC50: 14 nM

99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

Lificiguat 生物活性

靶点
  • HIF

描述 YC-1 is an allosteric activator of soluble guanylyl cyclase (sGC). YC-1 exerts antiplatelet effects through the sGC/cyclic GMP pathway[4]. It increased the catalytic rate of the enzyme and sensitizes the enzyme toward its gaseous activators nitric oxide or carbon monoxide. YC-1 activation of sGC can occur independently of heme, but that activation is substantially increased when the heme moiety is present in the enzyme. Administration of YC-1 to experimental animals resulted in the inhibition of the platelet-rich thrombosis and a decrease of the mean arterial pressure, which correlated with increased cGMP levels[5].
作用机制 YC-1 increases the maximal catalytic rate and sensitizes the enzyme toward its gaseous activators by binding to an allosteric site on sGC molecules, thereby reducing the ligand dissociation rate from the heme group.[6]

Lificiguat 细胞研究

细胞系 浓度 检测类型 检测时间 活动说明 数据源
A498 cells Cytotoxicity assay 48 h Cytotoxicity against human A498 cells incubated for 48 hrs by MTT assay, IC50=0.3 μM 26235951
ACHN cells Function assay 48 h Antitumor activity against human ACHN cells after 48 hrs by MTT assay 20097456
AGS cells Function assay Inhibition of hypoxia induced HIF1 transcriptional activity in human AGS cells by cell-based HRE reporter assay, IC50=2 μM 17328532
HCT116 cells Cytotoxicity assay 72 h Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay, IC50=2.2 μM 24900662

Lificiguat 动物研究

Dose Mice: 30 mg/kg, 60 mg/kg[4] (i.p.); 6.96 mg/kg[5] (i.v.) Rat: 1 mg/kg[6] (i.p.)
Administration i.p., i.v.

Lificiguat 参考文献

[1]Wu CC, Ko FN, et al. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Br J Pharmacol. 1995 Oct;116(3):1973-8.

[2]Martin E, Lee YC, et al. YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components. Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):12938-42. Epub 2001 Oct 30.

[3]Friebe A, Koesling D, et al. Mechanism of YC-1-induced activation of soluble guanylyl cyclase. Mol Pharmacol. 1998 Jan;53(1):123-7.

[4]Wu CC, Ko FN, Kuo SC, Lee FY, Teng CM. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Br J Pharmacol. 1995 Oct;116(3):1973-8. doi: 10.1111/j.1476-5381.1995.tb16400.x. PMID: 8640334; PMCID: PMC1908948.

[5]Martin E, Lee YC, Murad F. YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components. Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):12938-42. doi: 10.1073/pnas.231486198. Epub 2001 Oct 30. PMID: 11687640; PMCID: PMC60803.

[6]Friebe A, Koesling D. Mechanism of YC-1-induced activation of soluble guanylyl cyclase. Mol Pharmacol. 1998 Jan;53(1):123-7. doi: 10.1124/mol.53.1.123. PMID: 9443939.

Lificiguat 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.29mL

0.66mL

0.33mL

16.43mL

3.29mL

1.64mL

32.86mL

6.57mL

3.29mL

Lificiguat 技术信息

CAS号170632-47-0
分子式C19H16N2O2
分子量 304.342
别名 YC-1
运输蓝冰
存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Sealed in dry,Room Temperature

溶解度

DMSO: 105 mg/mL(345.01 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。